France, worried about the outbreak of the third wave of the Epidemic, announced that Paris will be closed for a month from Friday (19). The European authorities said on Thursday (18) that the benefits of administering the AstraZeneca vaccine outweigh the risks and that several European countries, including Germany and France, will resume administering the AstraZeneca vaccine.
Paris will enter a new round of city closures for a month from midnight Friday, French Prime Minister Jean Castex said, adding that the lockdown is not as strict as previous ones and that people will be able to exercise outdoors and schools and essential stores will remain open. In addition, the national curfew will remain in effect, but will be delayed by one hour until 7 p.m.
As in all parts of France, Paris has been under curfew since mid-January, and cafes, restaurants, bars and cinemas must be closed for a specified period of Time, but the number of confirmed cases has continued to climb so far, and the health care system is under increasing pressure.
France has added more than 35,000 new cases in the past 24 hours, and Castex said the possibility of a third wave of the outbreak is rising. According to public health authorities, Paris is in the most critical situation, with 1,200 patients in emergency intensive care units, more than the peak of the second wave of the epidemic last November.
France also announced that it will resume administering the AstraZeneca vaccine from Friday as the European Medicines Agency (EMA) review confirmed the safety and effectiveness of the vaccine, hoping to speed up the mass vaccination in France.
In addition to France, Germany, Italy, Cyprus, Latvia and Lithuania are among the European countries that have announced the resumption of vaccination operations. Spain is still evaluating the possibility of resuming administration.
The EMA said Thursday that a safety committee review confirmed that the company’s vaccine was safe and effective and that the benefits of vaccination outweighed the potential risks, although a link between the vaccine and blood clots cannot be completely ruled out at this time and will continue to be investigated.
The World Health Organization (WHO) this week also called on countries to continue administering the Astellicam vaccine.
The current pace of vaccination in Europe lags far behind that of the United Kingdom and the United States. The U.S. Food and Drug Administration (FDA) has not yet approved the AstraZeneca vaccine, pending the results of trials.
The U.S. government also announced on Thursday that it will send 4 million doses of the Astellicam vaccine to Mexico and Canada.
Recent Comments